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SECTION I: EXECUTIVE SUMMARY 
Prevention of infection during the healing process in tissue is a major concern and is 
especially  crucial  for  the  health  of  the  patient.  In  order  to  combat  infection  due  to 
bacteria, antibiotics must be deployed in the tissue at a high enough concentration for a 
long  enough  period  of  time  in  order  to  be  deemed  effective.  Historically,  systemic 
antibiotics  have  been  administered  to  diminish  the  threat  of  infection,  either  through 
intravenous injection or oral ingestion. However, toxicity levels of the drug in the entire 
body must be taken account,  lowering the efficacy of systemic antibiotics. Implanted 
antibiotic beads provide an attractive alternative by locally administering the antibiotics 
to the injured soft tissue, allowing higher concentrations of antibiotics to be delivered 
over a longer period of time, thus increasing the efficacy and safety of the drug. Although 
these beads must be physically placed into the injured soft tissue, a string of them can 
easily be implanted as the last step of surgery as a protective measure against future 
infections.   
 
The  goal  of  this  project  is  to  model  the  delivery  of  vancomycin-impregnated 
biodegradable antibiotic beads as the vancomycin diffuses into the injured soft tissue.  
 We constructed the model using 2D-axisymmetric geometry in COMSOL.  Our bead 
was comprised of two separate layers, one made of Polylactic Acid containing the initial 
drug concentration of vancomycin of 12.9 mol/m
3, and an outer layer of Polylactide-
Polyglycolide Copolymer (PLA-PL:CG), containing no vancomycin.  
 
We successfully modeled the shrinking of the biodegradable bead and were able to get 
results that agreed with other experimental data. These results included collecting data for 
concentrations of vancomycin in the tissue over time and space.  For vancomycin to be 
successful  in  fighting  infection,  the  concentration  needs  to  be  above  the  minimum 
effective level  while remaining below the toxic level.   Using these requirements,  we 
determined the optimal spacing between multiple beads to be 0.56cm.  
 
Our model can be used in place of experimentation to determine the optimal combination 
of parameters that meet a patient’s needs.  This model allows estimation of concentration 
profiles  in  the  tissue  that  would  otherwise  be  difficult  to  gather  in  an  experimental 
setting.  Therefore, our model can be used as  a tool for physicians  to  better prevent 
infection in traumatic injuries and surgeries. 
 
 
 
Key words: antibiotic bead implants, vancomycin treatment, PLA bead, PLA-PL:CG 
polymer coating, antibiotic diffusion 
   4 | P a g e  
 
SECTION II: INTRODUCTION AND BACKGROUND 
 
2.1 Introduction and Background 
 
Open Wound Surgery and Infection 
During open wound surgery, the prevention of wound site infection is paramount to the 
healing and recovery process of injured soft tissue. Bacteria residing in the dead space of 
tissue  debridement  present  the  biggest  threat  of  infection  in  the  healing  tissue.  
Consequently, significant preventative measures must be taken.  Otherwise, infections 
may  cause  complications  such  as  prolonged  hospital  stays,  increased  rehabilitation 
periods, repeated debridements, morbidity, and mortality (Edwards, et al 2008, 770-777). 
Although advances in aseptic and sterilization technologies have vastly diminished the 
threat of infection, the prevention of infection still remains a significant issue in patient 
health. 
 
Staphyloccocus  aureus  is  the  gram-positive  bacteria  most  commonly  found  to  cause 
infections during and after open would surgery. S. aureus is normally found living on 
human skin, but can be life-threatening to the patient (Kluytmans, et al 1997, 505-520). 
when entering the body through the wound site. In a study done by Khan et al., it was 
determined that S. aureus was the main causative bacterial agent in infection during open 
wound surgery at least 50% of the time (Khan, et al 2008, 23-25). Therefore antibiotic 
treatment  against  S.  aureus  would  likely  be  sufficient  in  preventing  most  bacterial 
infections.  Vancomycin,  an  antibiotic  effective  against  gram-positive  bacteria,  could 
therefore  be  an  effective  treatment  for  infections  resulting  from  surgery  or  traumatic 
injuries. 
 
Antibiotic Bead Implants 
Systemic antibiotics are normally used for treatment against bacterial infection after open 
wound surgery. These can be administered intravenously or orally. However, intravenous 
injection can be seen as invasive or tedious because of repetitive injections, while oral 
administration of antibiotics often yields unpredictable concentrations. Because systemic 
drugs circulate throughout the entire body, there is a risk of reaching toxic levels in the 
kidney. Antibiotic bead implants provide an attractive alternative to systemic antibiotics 
by supplying a prolonged, controlled release of antibiotics over longer periods of time. 
Antibiotic beads also supply drug to localized tissue, increasing the effective amount of 
antibiotics  reaching  the  injury  site  while  avoiding  the  risk  of  kidney  toxicity. 
Biodegradable beads also resorb slowly into the body, eliminating the need for secondary 
surgery for bead removal (Liu, et al 2002, 807-813). As shown in Figure 1, multiple 
antibiotic beads can be strung together and placed inside the wound site during the open 
wound surgery. 
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Figure 1. Insertion of multiple antibiotic beads during open wound surgery 
 
2.2 Design Objectives 
 
Due  to  the  unpredictable  behavior  of  drugs  in  the  body,  accurate  modeling  of  the 
diffusion of vancomycin in the injured tissue is necessary before surgery. Modeling can 
reduce the need for experimentation while also providing more insight into the diffusion 
process. To avoid reaching toxic drug levels while still maintaining minimum effective 
concentrations  in  the  tissue,  we  need  to  consider  spatial  and  transient  concentration 
profiles. Therefore, we plan to: 
 
1)  Model the diffusion of vancomycin out of the bead into the injured soft tissue 
2)  Determine the effective time period and diffusion distance of the drug  
3)  Model the physical shrinking of the antibiotic bead over time 
4)  Determine the optimal spacing between beads  
5)  Validate our model using published experimental data  
2.3 Problem Schematic 
 
We used COMSOL Multiphysics software to model the diffusion of vancomycin into the 
tissue over time. Because the shape of our antibiotic bead is  spherical,  we used 2D-
axisymmetric geometry. The rotational symmetry of the bead allowed us to simplify the 
model to include only a quarter of the sphere. Our antibiotic bead model was comprised 
of two separate layers; the inner layer was made of PLA and the outer layer (polymer 
coating)  was  made  of  PLA-PL:CG.  Only  the  inner  layer  contained  an  initial  drug 
concentration. 
 
As shown in Figure 2, we modeled the bead with an inner radius of 4mm and an outer 
polymer coating layer with a thickness of 1mm. Surrounding the bead is a region of soft 
tissue that extends 1cm from the center of the bead, which is sufficiently large to model 
the entire concentration behavior of the vancomycin diffusion in the tissue. As indicated 
on the schematic, the bead and polymer coating shrink over time. 
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Figure 2. Problem schematic of vancomycin bead in tissue 
   
The top and left boundaries have a mass transfer flux of zero due to symmetry. The right 
and  bottom  boundaries  also  have  a  mass  transfer  flux  of  zero,  because  they  can  be 
considered at  a far enough distance where the drug never reaches the  boundary. The 
initial inner bead concentration is 12.9mol/m
3. The concentration of vancomycin in the 
tissue was also assumed to be zero initially. 
 
We used this schematic, along with the appropriate governing equations, as the basis for 
our COMSOL model. 
2.4 Governing Equations 
 
The governing equation for the antibiotic bead model is the generalized mass transfer 
governing equation in cylindrical coordinates without the convection term. Cylindrical 
coordinates  are  required  for  this  problem  because  we  needed  two  dimensions  for  a 
moving  boundary  in  COMSOL.  The  convection  term  is  omitted  as  there  is  no  flow 
present in our model. Because COMSOL uses a finite mesh and the software does not 
allow mesh to disappear over time, the shrinking of the bead is modeled as a moving 
boundary. The governing equation is: 
 
              (1)  
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The  diffusion  of  vancomycin  in  the  tissue  needs  to  also  include  a  clearance  term  to 
account for metabolic degradation and removal of vancomycin due to blood flow (not to 
be confused with convective flow). In order to account for this behavior, clearance of 
vancomycin is modeled as a first-order reaction based on the half-life of vancomycin, 
which has been adapted from the vancomycin microcapsule elution model done by Pettiti 
et al (Pettiti 2009, 859-866). 
 
                  (2) 
 
                    (3) 
 
R is the clearance term, k is the rate constant, and t1/2 is the half-life of vancomycin 
(Ducharme, et al 1994, 513-518).  
 
2.5 Model Design and Conditions 
 
As stated earlier, the physical geometry of the bead shrinks over time as the vancomycin 
diffuses into the tissue. We used a moving boundary to account for the disappearance of 
the outer layer by having the bead boundary shrink at a constant velocity up to a certain 
point in  time. The mesh of the outer layer cannot  completely disappear, so  once the 
shrinking outer layer has nearly reached the inner bead, the region that was designated as 
the outer layer was then given the properties of the surrounding tissue. At this time, the 
inner bead began to shrink at a constant velocity, although different from that of the outer 
layer. We also included the regrowth of tissue to account for the shrinking of the bead 
over time. See Appendix A for numerical values and calculations of parameters.  Our 
shrinkage  and  tissue  growth  values  were  based  on  previous  experimental  data  using 
vancomycin  antibiotic  beads  (Mader,  et  al  1997,  415-418).
   The  minimum  effective 
concentration of vancomycin for antibacterial activity is 0.0021mol/m
3 (Hook 1978, 411-
415).
  The  maximum  concentration  of  vancomycin  before  reaching  toxic  levels  is 
0.4mol/m
3 (Edin, et al 1996, 245-251). All other parameters involved in the solving of the 
model are detailed in Appendix A.  
 
We  made  some  simplifying  assumptions  for  the  model.  These  included  uniform  and 
constant tissue and bead properties and perfect spherical geometry of the bead. The string 
connecting the beads was also considered negligible. The shrinkage velocities of the bead 
layers were assumed to be constant. Finally, the input parameters were estimates from 
experimental data collected from literature (Mader, et al 1997, 415-418), (Ducharme, et 
al 1994, 513-518), (Hook 1978, 411-415). 
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SECTION III: RESULTS AND DISCUSSION 
 
3.1 Modeling Vancomycin Concentration Profile 
 
We modeled the concentration profile of the vancomycin bead using the above schematic 
and listed parameters. In COMSOL, we constructed the schematic using an unstructured 
fine mesh. See Appendix C for mesh convergence analysis. We ran the simulation for a 
total of 28 days at a time step of 1 hour which closely approximates the entire healing 
process of tissue recovery after surgery. Figure 3 shows a surface plot of the vancomycin 
concentration in the tissue after the full 28 day treatment with the vancomycin bead.  
 
 
Figure 3. Surface plot concentration profile of vancomycin diffusion only in soft tissue 
after 28 day treatment 
 
Analysis of the surface plot confirms that concentration levels of vancomycin are in fact 
above the minimal effective level well outside the radius of the bead in the tissue region. 
Once the model was confirmed to deliver sufficient concentrations of vancomycin to the 
surrounding tissue region, we analyzed how the diffusion of vancomycin into the tissue 
changed over time.  
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3.2 Analysis of Vancomycin Diffusion as a Function of Distance 
 
For our model to be deemed successful, the concentration of vancomycin in the tissue 
must remain below the toxic level while remaining above the minimal effective level. A 
concentration profile for vancomycin over an increasing radial distance from the bead 
was  plotted  for  several  weeks.  Figure  4  shows  a  relatively  constant  concentration 
behavior  curve  for  one  to  four  weeks  of  vancomycin  treatment.  The  vancomycin 
concentration decreases as the radial distance from the bead increases. As expected, the 
concentration of vancomycin in the tissue gradually decreases over the treatment span of 
four weeks.  
 
 
 
Figure 4: Concentration profile of vancomycin over radial distance from the center of 
the bead (initial bead radius = 5mm) at weekly intervals.  
 
For all four weeks, the concentration of vancomycin consistently stayed below the toxic 
level of 0.4mol/m
3 in the tissue.  The maximum vancomycin concentration in the tissue 
was  at  the  bead-tissue  interface  after  one  week  of  treatment,  with  a  value  of 
approximately 0.17mol/m
3.  Based on these concentration profiles, we were then able to 
optimize the bead spacing. 
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3.3 Optimization of Individual Antibiotic Bead Spacing 
 
Our  next  step  was  to  determine  the  optimal  amount  of  spacing  between  multiple 
vancomycin beads for placement during surgery. After determining that the toxic level 
for  vancomycin  was  not  reached  over  the  treatment  span,  our  main  concern  became 
keeping the vancomycin level in the tissue above the minimum effective level through 
the  fourth  week.  Figure  5  shows  a  magnified  view  of  Figure  4,  specifically  the 
concentration curves over the range of 7mm to 8.2mm from the bead center. Figure 5 
shows that after four weeks, vancomycin  concentration in  the tissue drops below the 
minimum effective level of 0.0021mol/m
3 at 2.8mm from the edge of the bead, which is 
7.8mm from the center of the bead. At this distance, the concentration drops below the 
minimum effective level after week four. 
 
 
Figure 5: Concentration profile of vancomycin over radial distance from the center of 
the bead at weekly intervals. 
 
Based on this data, the next bead must be placed approximately 0.56cm away from the 
initial bead in order to ensure that all tissue between the beads has an effective level of 
vancomycin. If antibiotic treatment requires a longer treatment span than four weeks, a 
bead with a higher initial concentration would be needed in order to minimize the number 
of beads needed. Because this plot shows concentrations only at discrete times, we found 
it necessary to also analyze concentrations as a function of time. 
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3.4 Analysis of Vancomycin Diffusion as a Function of Time 
 
Analyzing the concentration behavior of vancomycin at specific radial distances from the 
bead provided a better understanding of the diffusion of the antibiotics. We analyzed the 
results  for  the  entire  duration  of  treatment  rather  than  at  interval  weeks.  We  had  to 
confirm  that  the  concentration  of  vancomycin  remained  within  the  effective  range. 
Therefore,  we  plotted  the  concentration  of  vancomycin  over  time  at  the  bead  tissue 
interface, at 1 mm from the interface, and at 2.5 mm from the interface.  In Figure 6, 
these locations are represented as points A, B and C, respectively. 
 
 
 
 
 
 
Figure 6: Depiction of points A, B and C, used for concentration profiles over time. 
 
Figure 7 shows concentration profiles at the points shown in Figure 6.  The three curves 
in Figure 7 represent the concentrations at the points over the 28 day period. The 
minimum effective concentration is also depicted on the graph. 
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 Figure 7: Concentration over time for Points A, B, and C. Minimum effective 
concentration, of 0.0021 mol/m
3, is also shown.  
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Figure 7 shows that at early times, the drug has yet to diffuse through the polymer layer 
and reach the tissue. Therefore, the concentration in the tissue is approximately zero for 
the first few days. At around 4.5 days (0.4x10
6s on the graph), the polymer coating is 
completely dissolved which corresponds to the change in slope of the peak.   This slope 
change is due to the change in diffusivity values, resulting from the way we handled the 
mesh  limitation  in  COMSOL.  This  was  discussed  earlier  in  Section  2.5.    As  time 
increases  after  this  peak,  the  concentration  gradient  decreases  as  more  vancomycin 
diffuses out of the bead and into the tissue. The decrease in concentration gradient of 
vancomycin  combined  with  the  metabolic  clearance  mentioned  earlier  causes 
vancomycin concentration to gradually decrease over time.  
 
The concentration in the tissue remains within the desirable range, 0.0021mol/m
3 to 0.4 
mol/m
3, for the duration of the treatment of four weeks. Based on the profiles for these 
three points, we can assume that all points will have the same concentration profile shape 
overtime.  Therefore,  this  confirms  our  solution  of  0.56  cm  as  the  optimum  spacing 
between beads. 
 
3.5 Accuracy Check 
 
In  order  to  validate  our  results,  we  compared  our  model  to  experimental  data  from 
literature. An accuracy check is necessary in order to validate the assumptions we used to 
construct our model. Ueng et al. studied biodegradable alginate antibiotic beads used to 
deliver vancomycin in rabbits in vivo (Ueng, et al 2004, 592-599). This study looks at the 
concentrations in the femoral bone cavity over time.  We used these results to ensure that 
our assumptions were valid.  
 
We compared our results to that of Ueng et al. by superimposing the concentration curve 
from this data over our own data, previously depicted in Figure 7.  This is presented as 
the accuracy check curve in Figure 8.   
 14 | P a g e  
 
0.00
0.03
0.05
0.08
0.10
0.13
0.15
0.18
0.20
0.23
0.25
0.28
0.0 0.5 1.0 1.5 2.0 2.5
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
m
o
l
/
m
3
)
Time (s) 
Concentration in Tissue vs. Time
Point A Point B Point C Minimum Effective Concentration Accuracy Check
x106
 
 
Figure 8. Result graph with accuracy check data from Ueng et al. 
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There are obvious similarities between our COMSOL model and the experimental results. 
In  both  data  sets,  the  concentration  curve  shows  a  significant  rise  in  concentration, 
peaking around three or four days (0.25-0.45 x 10
6 s), and then a steady decrease of drug 
concentration. As shown in Figure 8, the accuracy check curve best resembles the curve 
for Point C.  This makes sense because the concentrations in the study were measured in 
the bone cavity, not very close to the bead. This corresponds best to Point C because it is 
at the distance farthest from the bead.  
 
Discrepancies between the experimental set up of Ueng et al. and our model should be 
noted. Their antibiotic bead design uses poly-L-lysine sodium alginate as their coating 
layer while we use PLA-PL:CG polymer coating. They used a bead of diameter 3mm, 
whereas  our  bead  had  a  diameter  of  10mm.  This  difference  may  play  a  role  in  the 
concentration behavior over time. Furthermore, instead of placing their antibiotic beads 
within tissue as  we  have modeled, Ueng  et  al.  placed them  within the femoral  bone 
cavities  of  rabbits.  The  femoral  cavity  in  rabbits  may  have  a  different  effect  on 
vancomycin behavior than would the tissue in humans. All of these discrepancies may 
contribute to the variation in results. 
 
3.6 Sensitivity Analysis 
 
After  we  validated  our  solution  with  experimental  data,  it  was  important  for  us  to 
determine the parameters that had the largest effect on our results. For our sensitivity 
analysis,  we  altered  the  values  of  the  following  parameters  by :  diffusivity  of 
antibiotics in  the bead,  diffusivity of antibiotics in  the tissue, initial  concentration  of 
antibiotics  in  the  bead,  and  the  clearance  term  for  vancomycin.  We  changed  one 
parameter at a one, while keeping all others the same. We examined the resulting changes 
at a distance of 6mm from the center of the bead after four weeks.  
  
Figure 9 shows that our simulation is relatively robust in terms of tissue diffusivity and 
bead  diffusivity,  but  is  more  sensitive  to  the  initial  concentration  in  the  bead  and 
clearance term for vancomycin.  
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Figure 9: Sensitivity analysis for selected model parameters  
 
 
As shown in Figure 9, each parameter has a different effect on the concentration in the 
tissue.  Changes in tissue diffusivity and bead diffusivity are relatively unimportant.  This 
is reassuring because the exact values of the diffusivities are unknown. On the other 
hand, the model is very sensitive to initial concentration.  This is convenient because it is 
it is one of the easiest parameters to adjust when manufacturing the beads. There is also a 
considerable amount of sensitivity in the clearance term for vancomycin. This means that 
the model is heavily dependent on the half-life of vancomycin in the tissue. Although the 
clearance term has a significant impact on the results, the half-life can be determined 
from  experimental  data,  and  therefore  the  clearance  term  does  not  compromise  the 
validity of our model.  
 
SECTION IV: CONCLUSIONS AND RECOMMENDATIONS 
 
4.1 Conclusions and Design Recommendations  
 
We successfully created a model of an antibiotic bead that shrinks and releases antibiotics 
over time. For our specific model parameters, with an initial concentration of 12.9mol/m
3 
in the inner bead, we found concentration profiles over both time and space. This led us 
to  determine  the  optimal  bead  spacing  of  0.56cm,  which  allows  for  effective  drug 
delivery without reaching toxic levels.  
 
From the sensitivity analysis, we learned that the initial concentration of vancomycin in 
the inner part of the bead and the clearance term are important parameters of the model. 
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Both affect the final concentration in the tissue and the treatment duration.  While the 
clearance term is  patient-dependent and thus unalterable, the initial concentration can 
easily be changed during manufacturing.  
 
This  model  can  be  used  by  medical  professionals  to  test  different  properties  and 
parameters and determine the optimal combination of bead materials, drug composition, 
bead  spacing,  number  of  beads,  etc.,  that  meets  each  patient’s  needs.  Our  model  is 
flexible enough so that given a specific bead material, the medical professional can alter 
these other properties and parameters to optimize treatment.  We recommend determining 
the appropriate initial concentration first, then refining the bead design by changing the 
other properties and parameters. 
 
4.2 Realistic Constraints 
 
Antibiotic beads have been clinically used for over thirty-five years. In 1974, the first 
antibiotic beads were placed into patients, however these were not absorbable. They were 
commonly made of polymethyl methacrylate and were required to be removed from the 
patient after the antibiotics had completely diffused into the surrounding tissue (Freed 
and Demas 2010). Concerns regarding the use of nonabsorbable beads included the need 
for a second surgery to remove the bead, potentially harmful foreign body responses, and 
possible development of antibiotic-resistant organisms (Zalavras, et al 2004, 86-93).   
 
In order to address these issues, absorbable antibiotic beads were developed. These 
absorbable beads are often made of biodegradable polymers, such Polylactic acid and 
Polygylcolic acid, mixed with antibiotics, such as vancomycin or tombramycin (Liu, et al 
2002, 807-813).  Absorbable antibiotics beads are currently being manufactured by 
companies such as OsteoSet®. Traditionally, the beads are manufactured by hand using 
molds of specified dimensions. Different materials are used to customize antibiotic beads.  
 
While some of the concerns related to the non-absorbable beads were addressed, other 
concerns  regarding  the  use  of  absorbable  beads  have  developed.  The  consistency  of 
biocompatibility of the beads is a concern, as well as maintaining effective antibiotic 
concentrations for prolonged periods of time. However, the benefits of using absorbable 
beads outweigh the possible consequences, thus over the past ten years absorbable beads 
have mostly replaced the use of nonabsorbable beads.  
 
In comparison to systemic antibiotics, absorbable antibiotic beads have been reported to 
have  reduced  costs  (Zalavras,  et  al  2004,  86-93).  Studies  have  shown  that  a  35-day 
intravenous treatment using vancomycin cost over $13,000 (Susman, 2005).  The cost of 
antibiotic bead treatment has been estimated to be around $500 (Wright, et al 2007, 129).  
Due to the reduced costs as well as associated advantages with using beads, this method 
of antibiotic administration is preferable.  
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4.3 Future Work  
 
There are several possibilities of expanding and improving upon our vancomycin bead 
model.  One  includes  developing  an  equation  for  the  optimal  bead  spacing  for  given 
parameters. We would need to run the simulation using different sets of parameters, and 
then develop an equation that relates those parameters to the bead spacing. Developing 
such an equation would improve usability of the model, allowing others to determine 
optimal spacing solutions without complex knowledge of COMSOL. Other future work 
may involve incorporation of multiple layers with differing vancomycin concentrations. 
This could allow us to analyze the effect of multiple layers on drug delivery to the tissue. 
Finally, the implementation of the shrinking bead could be improved. The shrinking bead 
in our model has significant limitations in its COMSOL meshing implementation, due to 
restrictions of the COMSOL software. Although changing the parameters of the outer 
bead layer at different shrinkage points is the most adaptive solution given COMSOL 
meshing requirements, the fact still remains that the simplification is a crude approach.  
SECTION V: APPENDICES 
 
5.1 Appendix A – Input Parameter Values and Calculations 
 
Table 3. Input Parameter Values for Vancomycin PLA-PL:CG Bead 
Parameter  Symbol  SI Units  Value  Reference 
Velocity of Bead 
Shrinkage 
vbead  m/s  -2.572 x 10
-10 for 
t ≤ 432000 seconds 
(Mader et al 1997, 415-
518) 
Velocity of Tissue 
Growth 
vtissue  m/s  -2.316 x 10
-9 for 
t > 369250 seconds 
(Mader et al 1997, 415-
518) 
Half-life of 
Vancomycin 
t1/2  s  23400 s  (Ducharme, et al 1994, 
513-518) 
 
Diffusivity of PLA-
PL:CG copolymer 
Dpolymer  m
2/s  2.5 x 10
-13 for 
t < 369250 seconds; 
5.502 x 10
-11
 for 
t ≥ 36950 
(Hook 1978, 411-415) 
Diffusivity of inner 
bead layer 
Dinner bead  m
2/s  2.5 x 10
-13  (Hook 1978, 411-415) 
Diffusivity of tissue  Dtissue  m
2/s  5.502 x 10
-11  (Hook 1978, 411-415) 
 
Calculations for Velocity of PLA-PL:CG copolymer 
 
From the experimental data, it was given that the copolymer shrunk 8mm after 40 days in 
PBS solution (Mader et al 1997, 415-518).  
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Calculations for the Velocity of Bead Shrinkage 
 
From experimental data, it was given that the inner part of the bead solution with 
vancomycin shrunk 4mm after 180 days in PBS solution. 
   
 
 
5.2 Appendix B – COMSOL Specifications 
 
We used COMSOL Multiphysics software, implementing the UMFPACK direct solver. 
The time step used was 3600 seconds (one hour) and was run for a total of 28 days. The 
relative tolerance used was 0.01, and the absolute tolerance was 0.0010.  
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5.3 Appendix C – Mesh Convergence 
 
Table 4. Mesh Convergence Values for Antibiotic Bead after 28 Days 
Elements 
Concentration Integral in 
Tissue(mol/m
3) 
Surface 
Area (m
2) 
Average concentration 
in tissue (mol/m
3) 
408  3.687919E-07  8.65049E-05  4.263249E-03 
552  3.678681E-07  8.65049E-05  4.252570E-03 
720  3.677822E-07  8.65049E-05  4.251577E-03 
1110  3.681135E-07  8.65049E-05  4.255406E-03 
1698  3.680327E-07  8.65049E-05  4.254472E-03 
4208  3.680390E-07  8.65049E-05  4.254545E-03 
 
 
 
 
Figure 12. Mesh with 1698 elements       Figure 13. Mesh Convergence Graph of      
      Average Concentration 
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